Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Celiac Disease: early-phase trial registry
14 of 25 indexed Celiac Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 14 currently recruiting · #652 of 28,707 conditions by registered trial count
Celiac Disease: 25 US clinical trials tracked, 14 recruiting.
Celiac Disease is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is Nielsen Fernandez-Becker, running 2 of these trials.
Enrollment posture brief
Registry condition celiac-disease
OPEN 14 | RECR 56% | LATE 0 | EARLY 10 | RANK #652 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Marginal Zone Lymphoma (56% recruiting · 50 trials)
Celiac Disease lists 14 open slots (56% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Celiac Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Celiac Disease is recruiting above its size-band peers.
14 of 25 indexed trials (56%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Celiac Disease trials is spread across many organizations.
Nielsen Fernandez-Becker accounts for 2 of 25 trials (8%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Celiac Disease enrolment sits around 92 participants.
Median target enrolment is 92 among the 25 trials that report a genuine target (sentinel values excluded). 13 of those (52%) plan for fewer than 100 participants.
-
Celiac Disease splits between interventional and observational designs.
16 interventional and 9 observational studies make up this index (64% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Sanford Health
NCT04477928
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
NCT04806620
Urine Metabolites in the Diagnosis of Disease
Luventix
NCT06710067
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
Massachusetts General Hospital
NCT02061306
Immune Responses to Gluten
Boston Children's Hospital
NCT05209568
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
TScan Therapeutics
NCT06587828
Tissue Destruction and Healing in Celiac Disease
University of Chicago
NCT05680012
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
AdventHealth Translational Research Institute
NCT06908057
Gluten Technology and Education for Celiac Health
Columbia University
NCT06059716
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
NCT07239336
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
Teva Branded Pharmaceutical Products R&D
NCT06807463
VTP-1000 in Adults With Celiac Disease
Barinthus Biotherapeutics
NCT06310291
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Massachusetts General Hospital
NCT05636293
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Nielsen Fernandez-Becker
NCT07063823
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Sanofi
NCT06557772
Detection of Celiac Disease in Patients With Hypothyroidism
University of Vermont
NCT01862510
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
Takeda
NCT05353985
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
Capso Vision
NCT04573959
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
Mayo Clinic
NCT03288831
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion
NCT06001177
Gut Permeability Assessment in Celiac and Gluten Sensitive Children
Mayo Clinic
NCT02690532
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
Entero Therapeutics
NCT03011931
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
Regeneron Pharmaceuticals
NCT04614571
PTG-100 for Patients With Celiac Disease
Nielsen Fernandez-Becker
NCT04524221
A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)
Chugai Pharmaceutical
NCT05686369
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Celiac Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Celiac Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Celiac Disease page
25 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Celiac Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Nielsen Fernandez-Becker sponsors the most Celiac Disease trials on record, review their full trial history before evaluating a specific study. See Nielsen Fernandez-Becker's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Celiac Disease condition card totals 25 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.